单位:[1]Beijing Inst Technol, Sch Life Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China[2]Capital Med Univ, Beijing Friendship Hosp, Int Med Ctr, Beijing 100050, Peoples R China首都医科大学附属北京友谊医院[3]Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Med Engn,Dept Biophys, Xian 710061, Peoples R China
Free radicals, usually containing one or more unpaired electrons, are extremely unstable and highly reac-tive with other biological molecules. Recently, there has been increasing interest and substantial progress in exploring the double-edged roles of free radicals in biological systems. Particularly, nanotherapeutics based on free radical regulation have emerged as a new treatment modality against various diseases. Herein we provide a state-of-the-art review on free radicals as a double-edged sword in various disease treatments, which derives new opportunities for future nanotherapeutics. In this review, the major sources, types, and physiological functions of free radicals are firstly introduced. A specific focus is placed on the emergence of free radical generation-based nanotherapeutic approaches, including photodynamic therapy (PDT), sonodynamic therapy (SDT), radiation therapy (RT), chemodynamic therapy (CDT), ferrop-tosis therapy, and other nanotherapeutics involving free radical generation strategies. Subsequently, free radical depletion-based nanotherapeutics for alleviating molecular damage and related diseases are pre-sented with emphasis on the treatment of inflammatory diseases, neurodegenerative disorders, cardio-vascular and cerebrovascular diseases, acute kidney/liver injury, diabetes and diabetic complications, tumorigenesis and so on. Finally, some ongoing challenges and insightful perspectives of the currently developed nanotherapeutics based on regulating free radicals in biomedicine are discussed. We believe that this review would appeal to the researchers from interdisciplinarity fields of nanoscience, chemistry, biology, material science, pharmaceutical science, as well as clinical medicine to push the development of related nanotherapeutic technologies.(c) 2022 Elsevier B.V. All rights reserved.
基金:
National Natural Science Foundation of China [32001010, 81772915, 82073022]; Beijing Natural Science Foundation [2214078]; Natural Science Foundation of Shaanxi Province [2020JQ-086]; Beijing Institute of Technology Science and Technology Innovation Plan Project [2022CX01029]; Young Elite Scientist Sponsorship Program of Beijing Association for Science and Technology
第一作者单位:[1]Beijing Inst Technol, Sch Life Sci, Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhu Lin,Luo Meiying,Zhang Yinfeng,et al.Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics[J].COORDINATION CHEMISTRY REVIEWS.2023,475:doi:10.1016/j.ccr.2022.214875.
APA:
Zhu, Lin,Luo, Meiying,Zhang, Yinfeng,Fang, Fang,Li, Min...&Zhang, Jinfeng.(2023).Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics.COORDINATION CHEMISTRY REVIEWS,475,
MLA:
Zhu, Lin,et al."Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics".COORDINATION CHEMISTRY REVIEWS 475.(2023)